Drug intelligence / Profile preview

escitalopram + oxcarbazepine

Development stage
Unknown
Lead developer
Lundbeck
Modality
Small Molecules
Administration
Oral
01

Overview

Escitalopram + oxcarbazepine is a combination of two pharmaceutical drugs used primarily in the management of patients with comorbid epilepsy and depressive disorder. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant that increases serotonin levels in the brain by inhibiting its reuptake, thereby improving mood and anxiety symptoms. Oxcarbazepine is an anticonvulsant that stabilizes neuronal membranes by blocking voltage-sensitive sodium channels, reducing seizure activity. Clinical studies have shown that this combination can be effective for improving both seizure control and depressive symptoms in affected patients, though careful monitoring for drug interactions and side effects is required due to potential pharmacokinetic interactions[2][4][5][7].

02

Targets

NaV (Voltage-gated sodium channels)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on escitalopram + oxcarbazepine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on escitalopram + oxcarbazepine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call